{
Evonik Industries AG

Companies

}
001122334455554433221100
001122334455554433221100

ubs maintains neutral rating for evonik industries with target price of 18 euros

UBS has maintained a "Neutral" rating for Evonik Industries, setting a target price of 18 euros following the fourth quarter results. Analyst Geoff Haire noted that the forecast for the 2025 operating result (EBITDA) aligns with market expectations, and the current first quarter outlook is more favorable than that of comparable companies.
boerse.de
Euro Evonik Industries AG DEU CHE Geoff Haire
Finance & Economy, Market Report
10:40 05.03.2025

UBS Cuts Evonik Target Price to 18 Euros Maintains Neutral Rating

UBS has reduced its target price for Evonik Industries AG from €22 to €18 while maintaining a "Neutral" rating. Analyst Geoff Haire anticipates the company's fourth-quarter EBITDA will fall 6 percent below consensus estimates, with the earnings report scheduled for March 5. As of the latest trading, Evonik shares are priced at €16.72, reflecting a decline of 0.92%.
aktiencheck.de
Euro Evonik Industries AG DEU Geoff Haire
Finance & Economy, Market Report
10:36 18.12.2024

Evonik Industries Maintains Neutral Rating Amid Specialty Chemicals Market Developments

UBS has maintained a neutral stance on Evonik Industries AG, a German specialty chemicals company. Evonik focuses on the development, construction, distribution, and trading of scientific equipment, chemicals, and accessories for life sciences and biotechnology.
Zonebourse
Evonik Industries AG DEU
TradFi, Market Report
13:42 09.12.2024

growth forecast for singapore biomaterials in healthcare market through 2033

The Singapore Biomaterials in Healthcare Market is projected to grow from USD 214.5 million in 2023 to USD 771.5 million by 2033, at a CAGR of 13.66%. Key drivers include advancements in tissue engineering and government investments, while challenges stem from high production costs and lengthy regulatory approvals. The market is segmented into metallic, polymeric, ceramic, and natural biomaterials, with orthopedics expected to dominate applications.
Spherical Insights
Johnson and Johnson Evonik Industries AG BASF SE Medtronic SGP Show more
Healthcare, Market Report
15:54 18.11.2024

global pharmaceutical excipients market projected to reach 18 billion by 2033

The global pharmaceutical excipients market is projected to grow from $9.56 billion in 2023 to $18.01 billion by 2033, with a CAGR of 6.54%. Binders are the leading segment, enhancing drug formulation, while Asia-Pacific is expected to dominate market share due to cost advantages and rising healthcare demands. Europe will experience the fastest growth, driven by the influx of large pharmaceutical companies and the increasing need for innovative excipients.
Spherical Insights
United States Dollar Lubrizol Company Ashland Inc. Eastman Chemical Company Signet Chemical Corporation Pvt. Ltd Vertiv Holdings Co Dow Chemical Co. Valeant Pharmaceuticals International CORPORATION FMC Company Solutions Univar Inc. Wacker Chemie AG Evonik Industries AG P&G Chemicals Roquette Group Finar Limited ZAF FRA ITA CHN CAN DEU ESP ARE MEX USA BRA JPN GBR IND Show more
Healthcare, Market Report
13:45 08.11.2024

ubs maintains neutral rating for evonik with target price of 22 euros

UBS has maintained a 'Neutral' rating for Evonik Industries AG, setting a price target of 22 euros. Analyst Geoff Haire anticipates a neutral reaction to the upcoming quarterly report, noting that strong cash inflow and confirmed targets are positive indicators in the current market environment. As of November 6, 2024, Evonik's stock is trading at approximately 18.665 euros, reflecting a decline of 7.14% from the previous day.
aktiencheck.de
Euro Evonik Industries AG DEU Geoff Haire
TradFi, Market Report
09:40 06.11.2024

global veterinary healthcare market projected to reach 270 billion by 2028

The global veterinary healthcare market is projected to grow from $192.55 billion in 2023 to $270.68 billion by 2028, with a CAGR of 7.0%. Key growth drivers include rising pet ownership, zoonotic disease prevalence, and advancements in telemedicine and genomic medicine. North America remains the largest market, while major players include Zoetis Inc. and Merck & Co.
EIN News
United States Dollar Eli Lilly and Company Ceva Animal Health LLC Vetoquinol India Animal Health Pvt Ltd Merck & Co., Inc. MSD Animal Health UK Ltd. IDEXX Laboratories, Inc. Zoetis Inc. C.H. Boehringer Sohn AG & Co. KG National Veterinary Associates Inc. Phirbo Animal Health Evonik Industries AG Boehringer Ingelheim GmbH Patterson Companies, Inc. Pets at Home Group Plc CHN FRA RUS JPN USA BRA KOR DEU GBR IND IDN AUS Show more
Healthcare, Market Report
02:00 05.11.2024

Evonik announces additional layoffs amid ongoing restructuring efforts

Evonik is implementing another round of layoffs, affecting around 260 employees, as part of a broader restructuring plan that could lead to up to 2,000 job cuts. The company is reevaluating its keto and pharma amino acid production sites in France and China while ceasing keto acid manufacturing in Hanau, Germany, by the end of 2025. This reorganization aims to transform Evonik into a "system solutions provider" focused on advanced pharmaceutical ingredients and innovative healthcare solutions.
Fierce Pharma
Euro Evonik Industries AG FRA DEU CHN Thomas Wessel Christian Kullmann Show more
Finance & Economy, News Article
09:00 14.10.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Finance Mergers & Acquisitions Banking Regulations Retail and Consumer Goods Startups & Entrepreneurship Central Bank Actions Industry Mergers & Acquisitions Inflation and Monetary Impact Government Economic Policies Market Analysis and Predictions CEO Changes Domestic Politics Government Policies Workplace Trends GDP Growth & Recession Forecasts Financial Scams and Security
Countries:
USA CHN GBR CHE IND DEU FRA JPN CAN VNM ARE ITA ESP SGP MEX AUS TWN THA MYS IDN
Companies:
Tesla, Inc. JPMorgan Chase & Co. Apple Inc. Barclays PLC Deutsche Bank Money Market PP The Goldman Sachs Group, Inc. Credit Suisse Strategic Income I Banco Santander, S.A. Berkshire Hathaway Inc. SpaceXCoin USD Lloyds Banking Group plc Bank of America Corporation Morgan Stanley Amazon.com, Inc. UBS Group AG BNP Paribas SA Wells Fargo & Company NVIDIA Corporation Bank Frick AG Citigroup Inc.
Currencies:
United States Dollar Euro British Pound Sterling Japanese Yen Swiss Franc Indian Rupee Chinese Yuan South Korean Won Vietnamese Đồng Canadian Dollar Australian Dollar Thai Baht Singapore Dollar Indonesian Rupiah New Taiwan Dollar Mexican Peso Russian Ruble Hong Kong Dollar Offshore Chinese Yuan New Zealand Dollar
People:
Donald Trump Elon Musk Warren Buffett JD Vance Sergio Ermotti Mark Haefele Robin Leopold Troy L Rohrbaugh Jennifer Piepszak Olivier Calvet Karoline Leavitt Ursula von der Leyen Scott Bessent Stacey Friedman George Saravelos Susan P. Crawford Francois Xavier Bouvignies Joseph Spak Stefan Rauti Greg Rubini

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.